Search
Grace Therapeutics, Inc
GRCEAdd to Watchlist
2.270USD
+0.030+1.34%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
36.37MMarket Cap
LossP/E TTM
Grace Therapeutics, Inc Earnings Date
Period
FY2026 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.47
40.37%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its current assets were 17.38M, with a year-on-year change of -23.48.
What are the total assets of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its total assets of Grace Therapeutics, Inc were 66.65M, with a year-on-year change of -7.42.
What are the total liabilities of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its total liabilities of Grace Therapeutics, Inc were 2.76M, with a year-on-year change of -48.76.
What is the total equity of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its total equity of Grace Therapeutics, Inc was 63.90M, with a year-on-year change of -4.07.
What is the net financing of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its net financing of Grace Therapeutics, Inc was 3.71M, with a year-on-year change of -73.54.
What is the Earnings Per Share (EPS) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -0.47, with a year-on-year change of 40.37.
What is the Return on Equity (ROE) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its Return on Equity (ROE) was -11.94, with a year-on-year change of 19.90.
What is the Return on Assets (ROA) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its Return on Assets (ROA) was -11.24, with a year-on-year change of 14.65.
What is the operating profit of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its operating profit was -11.08M, with a year-on-year change of 33.59.